date:Sep 25, 2012
cillus reuteri Protectis in infants and the effectiveness of our product in reducing symptoms of colic is now very clear, Peter Rothschild, President, BioGaia.
This new and strong data further strengthens the position of Lactobacillus reuteri Protectis within the paediatric field, he added.